Using hormone therapy to help new mothers avoid smoking relapse
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
This study is looking at how giving new moms a hormone called progesterone might help them avoid smoking again after having a baby, making it easier for them to stay smoke-free and protect their little ones from secondhand smoke.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10861712 on NIH RePORTER |
What this research studies
This research investigates how modifying hormone levels, specifically progesterone and estradiol, can help prevent new mothers from relapsing into cigarette smoking after childbirth. The study aims to deliver progesterone to postpartum women to reduce cravings and improve smoking abstinence rates. By understanding the hormonal influences on addictive behaviors, the research seeks to provide a safe intervention that could benefit both mothers and their children by reducing secondhand smoke exposure. Participants will be monitored for their smoking habits and health outcomes over a period of time.
Who could benefit from this research
Good fit: Ideal candidates for this research are postpartum women who have previously quit smoking during pregnancy but are at risk of relapse.
Not a fit: Patients who are not postpartum or who have never smoked may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce smoking relapse rates in postpartum women, leading to better health outcomes for both mothers and their infants.
How similar studies have performed: Previous research has shown promising results with hormone therapies in reducing smoking relapse, indicating that this approach may be effective.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Allen, Sharon S — University of Minnesota
- Study coordinator: Allen, Sharon S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.